OpenFilings
Oruka Therapeutics, Inc.
Form
8-K
Report Period
2024-08-29
Date Filed
2024-09-05
Time Filed
17:18:25
Document Analysis
Natural Language Processing
Recognized Type
Unidentified
Defined Term Format
Underlined
Italicized
Bold
Exhibits
CURRENT REPORT
CERTIFICATE OF AMENDMENT TO AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF
CERTIFICATE OF AMENDMENT TO AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF
CERTIFICATE OF AMENDMENT TO AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF
CERTIFICATE OF AMENDMENT TO AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF
AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF THE COMPANY, FILED SEPTEMBE
AMENDED AND RESTATED BYLAWS OF THE COMPANY
FORM OF CERTIFICATE OF ELIMINATION OF CERTIFICATE OF DESIGNATION OF PREFERENCES,
FORM OF CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF SER
ORUKA THERAPEUTICS, INC. 2024 STOCK INCENTIVE PLAN
ORUKA THERAPEUTICS, INC. 2024 EMPLOYEE STOCK PURCHASE PLAN
SECOND AMENDMENT TO AMENDED AND RESTATED ORUKA THERAPEUTICS, INC. 2024 EQUITY IN
FORM OF EMPLOYEE WARRANT AGREEMENT
CONSULTING AGREEMENT, EFFECTIVE AS OF AUGUST 30, 2024, BY AND BETWEEN ORUKA THER
CODE OF BUSINESS CONDUCT AND ETHICS OF ORUKA THERAPEUTICS, INC
LETTER FROM KPMG LLP, DATED SEPTEMBER 5, 2024
LIST OF SUBSIDIARIES OF ORUKA THERAPEUTICS, INC
PRESS RELEASE, ISSUED ON SEPTEMBER 3, 2024
AUDITED FINANCIAL STATEMENT OF ORUKA THERAPEUTICS, INC. AS OF FEBRUARY 6, 2024
UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS OF ORUKA THERAPEUT
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERA
UNAUDITED PRO FORMA FINANCIAL STATEMENTS OF ORUKA THERAPEUTICS, INC. AND ARCA BI
Filing on SEC Edgar